+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hyperthyroidism Drug"

Thyroid Gland Disorder Treatment Market by Disease Type, Drug Type, Route of Administration, and Distribution/Sales Channel: Global and Forecast up to 2027 - Product Thumbnail Image

Thyroid Gland Disorder Treatment Market by Disease Type, Drug Type, Route of Administration, and Distribution/Sales Channel: Global and Forecast up to 2027

  • Report
  • July 2023
  • 223 Pages
  • Global
From
Thyroid Gland Disorders Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Thyroid Gland Disorders Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 99 Pages
  • Global
From
Hyperthyroidism - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hyperthyroidism - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 101 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The Hyperthyroidism Drug market is a segment of the Endocrine and Metabolic Disorders Drugs market. Hyperthyroidism is a condition in which the thyroid gland produces too much of the hormone thyroxine, leading to an overactive metabolism. Common treatments for hyperthyroidism include antithyroid drugs, radioactive iodine, and surgery. Antithyroid drugs are the most commonly prescribed treatment, and are used to reduce the production of thyroxine. The Hyperthyroidism Drug market is highly competitive, with a number of large and small players. Companies in the market are focused on developing new drugs and treatments to meet the needs of patients. Many of these companies are also investing in research and development to improve existing treatments and develop new ones. Some of the major companies in the Hyperthyroidism Drug market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, and Takeda. Show Less Read more